Skandinaviska Enskilda Banken (SEB)
AMAG

Skandinaviska Enskilda Banken (SEB)’s AMAG Pharmaceuticals AMAG Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-108,300
Closed -$1.65M – 785
2018
Q4 		$1.65M Buy
108,300
+13,300
+14% +$253K 0.01% 536
2018
Q3 		$1.9M Buy
+95,000
New +$2.16M 0.01% 511
2018
Q2 		– Sell
-121,200
Closed -$2.44M – 748
2018
Q1 		$2.44M Sell
121,200
-59,000
-33% -$998K 0.02% 349
2017
Q4 		$2.39M Buy
180,200
+22,800
+14% +$344K 0.02% 403
2017
Q3 		$2.9M Sell
157,400
-8,300
-5% -$155K 0.03% 387
2017
Q2 		$3.05M Buy
165,700
+7,100
+4% +$141K 0.03% 381
2017
Q1 		$3.58M Buy
158,600
+49,700
+46% +$1.19M 0.04% 339
2016
Q4 		$3.79M Sell
108,900
-66,600
-38% -$1.99M 0.05% 271
2016
Q3 		$4.3M Sell
175,500
-36,500
-17% -$912K 0.05% 283
2016
Q2 		$5.07M Buy
212,000
+8,900
+4% +$204K 0.06% 246
2016
Q1 		$4.75M Sell
203,100
-37,100
-15% -$881K 0.05% 251
2015
Q4 		$7.33M Buy
+240,200
New +$7.76M 0.09% 162

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AMAG Position: Q1 2019 in Review

Skandinaviska Enskilda Banken (SEB) sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 108,300 shares — an estimated $1.65M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AMAG in Q4 2015 and held it in 12 quarters. The position peaked at $7.33M in Q4 2015. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 108,300 AMAG Pharmaceuticals shares in Q1 2019, an estimated $1.65M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 12 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s AMAG Pharmaceuticals position peaked at $7.33M in Q4 2015.
  • 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2019, filed 15 May 2019.